August 29, 2017
To whom it may concern:
Company name:OSAKA SODA CO, LTD.

Securities code:

4046 First Section, Tokyo Stock Exchange

Representative:

Kenshi Terada
Representative Director, Chief Operating Officer

For inquiry:

Shinichi Akamatsu
Director, Managing Executive Officer
Tel: +81-(0)6-6110-1560

Acquisition of Chromatography Business of Shiseido Company, Limited
OSAKA SODA CO., LTD. (the “Company”) today announced that effective August 29, 2017, the Company
and Shiseido Company, Limited (“Shiseido”) has entered into an agreement that the Company willpurchase all issued shares of Shiseido Irica Technology Inc., which is Shiseido’s consolidated subsidiary,
and will acquire Chromatography Business of Shiseido China Co., Ltd., which is Shiseido’s China-basedsubsidiary.
1. Share Purchase and Acquisition of Chromatography Business
The Company and its subsidiaries (“OSAKA SODA GROUP”) engages in nurturing and strengthening
the healthcare-related business which is positioned as OSAKA SODA GROUP’s third pillar of profit
under the mid-term management plan “NEXT FRONTIER-100. Especially in Separation Media in
Pharmaceutical Industry (Silica Gel for Liquid Chromatography), OSAKA SODA GROUP actively
invested our management resources including expansion of production capacity, alignment ofoverseas network, and development of purification materials for bio drug in order to reinforce HPLC
Silica Gel hold No.1 share position globally
Shiseido Irica Technology Inc. is a contract manufacturing company of HPLC Silica Gel, HPLC
Columns, and analysis equipment. It has highly reliable technology with a proven record of success.
As a result of consolidation, the Company’s Chromatography Business achieves to offer fully
integrated production from columns business to analysis equipment as well as providing a variety ofHPLC Silica Gel. Furthermore, the Company engages in development and manufacturing to meet
diversified customer’s needs and aims for expanding business field, creating the synergistic effect ofOSAKA SODA GROUP’s Active Pharmaceutical Ingredients and Intermediates.
OSAKA SODA GROUP expand sales in Asia including China through acquisition of the assets andmarketing rights associated with Chromatography Business of Shiseido China Co., Ltd.
Taking advantage of share purchase and acquisition of Chromatography Business, OSAKA SODAGROUP aims to enhance corporate value through expansion of the healthcare-related business andefforts to increase overseas presence.

2. Outline of Subsidiary(1)

Trade name:Shiseido Irica Technology Inc.

(2)

Representative:

Akihiro Ishino
Representative Director, President(3)

Business address:

12 Nishikawabe-cho, Higashikujyo Minami-ku, Kyoto, Japan(4)

Date of incorporation:

May 10, 1985

(5)

Business:

Manufacturing & selling of analysis equipment (columns,instrument, etc.)(6)

Fiscal year-end:

December 31(7)

Number of employees:

27 (including 3 employees on secondment from Shiseido)(8)

Place of business:

Headquarter in Kyoto(9)Capital:

100 million yen(10)Issued shares:

2,100 shares(11)

Most recent earnings
Shiseido Irica Technology Inc. – Single Entity
Fiscal Year Ended

Fiscal Year Ended

December 31, 2015

December 31, 2016

Sales

411 million yen

610 million yen

Operating Profit

11 million yen

11 million yen

The accounting period of Fiscal Year Ended December 31, 2016 is nine months due to shift toJanuary-December fiscal year from April-March fiscal year.
3. Share Purchase
The Company acquires shares from Shiseido.
There is no personal and capital relationship between the Company and Shiseido.
4. Share Ownership(1)

Number of shares held before share purchase0shares(2)

Number of shares purchased

2,100shares(3)

Number of shares held after share purchase2,100shares

Note 1ownership

0%ownership 100%

Prior to share purchase, the rights and obligations related to Chromatography Business ofShiseido shall be succeeded to Shiseido Irica Technology Inc. with a divestiture (absorptiontype split), Shiseido Irica Technology Inc. delivers 100 shares to Shiseido in exchange forthis transaction. Accordingly, both the number of shares purchased and the number ofshares held after share purchase are to be 2,100 shares which is issued shares increased
by divestiture.

Note 2A share purchase price is not disclosed in compliance with the confidentiality obligations ofshare purchase agreement with Shiseido.

5. Timetable
August 29, 2017Conclusion of Share Purchase Agreement

December 1, 2017

Effective Date of Share Purchase

6. Outlook
As a result of share purchase, Shiseido Irica Technology Inc. will be consolidated subsidiary ofOSAKA SODA GROUP.
There is no significant impact on the Company’s consolidated closing for Fiscal Year Ending
December 31, 2017.
7. Board of Directors
Two (2) members (director and auditor) of Shiseido Irica Technology Inc.’s board of directors will
resign their posts.